Association of hemoglobin, albumin, lymphocyte, and platelet score with risk of cerebrovascular, cardiovascular, and all-cause mortality in the general population: results from the NHANES 1999-2018

被引:34
作者
Pan, Hong [1 ]
Lin, Shasha [2 ]
机构
[1] Zhejiang Univ, Deqing Peoples Hosp, Sir Run Run Shaw Hosp, Sch Med,Dept Neurol, Deqing Campus, Huzhou, Peoples R China
[2] Wenzhou Med Univ, Affiliated Hosp 1, Dept Ultrasound, Wenzhou, Peoples R China
关键词
HALP score; cerebrovascular mortality; cardiovascular mortality; all-cause mortality; NHANES; PROGNOSTIC-FACTOR; HALP SCORE; CANCER; DISEASE; ANEMIA; COUNT;
D O I
10.3389/fendo.2023.1173399
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aimsCardiovascular and cerebrovascular disease (CCDs) contribute to leading causes of morbidity and mortality in the United States of America (USA). Hemoglobin, albumin, lymphocyte, and platelet (HALP) score, a simple and convenient indicator, could reflect the combination of inflammation and nutritional status. This study was undertaken to evaluate the associations between HALP score and risk of cardiovascular, cerebrovascular, and all-cause mortality in the general population from the National Health and Nutrition Examination Survey (NHANES) 1999-2018. MethodsWe identified 21,578 participants during the 1999-2018 cycles of the NHANES in this research. HALP score was calculated as hemoglobin (g/L) x albumin (g/L) x lymphocytes (/L)/platelets (/L). Outcomes were cerebrovascular, cardiovascular, and all-cause mortality determined by the NHANES-linked National Death Index record and followed until 31 December 2019. Survey-weighted Cox regression, restricted cubic spline analysis, and subgroup analysis were applied to investigate relationships between HALP score and risk of mortality. ResultsThis cohort study comprised 49.2% male and 50.8% female, of which the median age was 47 years old. In multivariate survey-weighted Cox regression adjusting for all confounders, compared with participants with low HALP scores, participants with highest HALP score had a lower risk of all-cause mortality (adjusted HR:0.80, 95% CI: 0.73, 0.89, P < 0.0001) and cardiovascular mortality (adjusted HR:0.61, 95% CI: 0.50, 0.75, P < 0.0001), and mediate HALP score had the lowest risk of all-cause mortality (adjusted HR:0.68, 95% CI: 0.62, 0.75, P < 0.0001) and cardiovascular mortality (adjusted HR:0.60, 95% CI: 0.48, 0.75, P < 0.0001). Restricted cubic spline analysis showed a non-linear relationship between HALP score and cardiovascular and all-cause mortality (all P values <0.001). ConclusionHALP score was independently associated with risk of cardiovascular and all-cause mortality, but not cerebrovascular mortality.
引用
收藏
页数:10
相关论文
共 43 条
[1]   Low Albumin Levels Are Associated with Mortality Risk in Hospitalized Patients [J].
Akirov, Amit ;
Masri-Iraqi, Hiba ;
Atamna, Alaa ;
Shimon, Ilan .
AMERICAN JOURNAL OF MEDICINE, 2017, 130 (12) :1465.e11-1465.e19
[2]  
Allison SP, 2001, CLIN NUTR, V20, P275, DOI 10.1054/clnu.2001.0440
[3]   Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction [J].
Azab, Basem ;
Shah, Neeraj ;
Akerman, Meredith ;
McGinn, Joseph T., Jr. .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2012, 34 (03) :326-334
[4]   Impact of Hemoglobin Levels and Anemia on Mortality in Acute Stroke: Analysis of UK Regional Registry Data, Systematic Review, and Meta-Analysis [J].
Barlas, Raphae S. ;
Honney, Katie ;
Loke, Yoon K. ;
McCall, Stephen J. ;
Bettencourt-Silva, Joao H. ;
Clark, Allan B. ;
Bowles, Kristian M. ;
Metcalf, Anthony K. ;
Mamas, Mamas A. ;
Potter, John F. ;
Myint, Phyo K. .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (08)
[5]   Platelets at work in primary hemostasis [J].
Broos, Katleen ;
Feys, Hendrik B. ;
De Meyer, Simon F. ;
Vanhoorelbeke, Karen ;
Deckmyn, Hans .
BLOOD REVIEWS, 2011, 25 (04) :155-167
[6]  
Caro JJ, 2001, CANCER-AM CANCER SOC, V91, P2214, DOI 10.1002/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.3.CO
[7]  
2-G
[8]   ESPEN guidelines on definitions and terminology of clinical nutrition [J].
Cederholm, T. ;
Barazzoni, R. ;
Austin, P. ;
Ballmer, P. ;
Biolo, G. ;
Bischoff, S. C. ;
Compher, C. ;
Correia, I. ;
Higashiguchi, T. ;
Hoist, M. ;
Jensen, G. L. ;
Malone, A. ;
Muscaritoli, M. ;
Nyulasi, I. ;
Pirlich, M. ;
Rothenberg, E. ;
Schindler, K. ;
Schneider, S. M. ;
de van der Schueren, M. A. E. ;
Sieber, C. ;
Valentini, L. i ;
Yu, J. C. ;
Van Gossum, A. ;
Singer, P. .
CLINICAL NUTRITION, 2017, 36 (01) :49-64
[9]   Prognostic significance of the combination of preoperative hemoglobin, albumin, lymphocyte and platelet in patients with gastric carcinoma: a retrospective cohort study [J].
Chen, Xiao-Long ;
Xue, Lian ;
Wang, Wei ;
Chen, Hai-Ning ;
Zhang, Wei-Han ;
Liu, Kai ;
Chen, Xin-Zu ;
Yang, Kun ;
Zhang, Bo ;
Chen, Zhi-Xin ;
Chen, Jia-Ping ;
Zhou, Zong-Guang ;
Hu, Jian-Kun .
ONCOTARGET, 2015, 6 (38) :41370-41382
[10]   The Efficacy of Hemoglobin, Albumin, Lymphocytes, and Platelets as a Prognostic Marker for Survival in Octogenarians and Nonagenarians Undergoing Colorectal Cancer Surgery [J].
Dagmura, Hasan ;
Daldal, Emin ;
Okan, Ismail .
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2022, 37 (10) :955-962